So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature [The Motley Fool]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: The Motley Fool
Investors know that drug development is an expensive and risky endeavor. Most drug candidates fail clinical trials, which is why the direct research and development necessary for each drug candidate that finally makes it to market costs hundreds of millions of dollars. That makes successful drug candidates exceedingly rare and valuable assets, especially for development-stage pharmaceutical companies that lack product revenue.Yet while most discussions about drug development consider late-stage clinical trials to be the ultimate end goal for investors, the reality is a little more complicated. Successful outcomes in phase studies don't guarantee success on the market.Investors have found this out the hard way withPuma BiotechnologyNASDAQ:PBYIAerie PharmaceuticalsNASDAQ:AERIRigel PharmaceuticalsNASDAQ:RIGLpharma stocksImage source: Getty Images.Tripped up by ramp upPuma Biotechnology earned initial marketing approval for Nerlynx neratinib) in July 07. The U.S. Food and Drug Administra
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer Canada and McMaster University to foster health equity in vaccine science [Yahoo! Finance]Yahoo! Finance
- Pfizer Canada and McMaster University to foster health equity in vaccine sciencePR Web
- Pfizer vs Moderna battle over COVID vaccine patents begins in UK [Reuters]Reuters
- Pfizer vs Moderna battle over COVID vaccine patents begins in UK [Yahoo! Finance]Yahoo! Finance
- Breast Cancer Market To Reach USD 4.3 Billion By 2032, Says DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 4/16/24 - Form 4
- 4/16/24 - Form 4
- 4/16/24 - Form PX14A6G
- PFE's page on the SEC website